BioFire Diagnostics

BioFire Diagnostics is a privately held clinical diagnostics company based in Salt Lake City, Utah. It currently holds more than 70 patents related to polymerase chain reaction (PCR), including rapid PCR cycling. Leveraging its extensive patent portfolio, the company has successfully brought nearly 200 products to the clinical, research, and military markets. The BioFire system is the new standard for syndromic infectious disease diagnosis. Simple, fast, and comprehensive, the BioFire system delivers accurate results in approximately one hour. The right test impacts all areas of patient care from the start. Healthcare providers can diagnose faster and improve antibiotic stewardship. Laboratories can see increased efficiency, reduced costs, and fewer downstream tests. With over 25 years of molecular expertise, BioFire Diagnostics, LLC has set the standard in molecular diagnostics through its pioneering advancements in syndromic infectious disease testing. As bioMérieux's global center of excellence for molecular diagnostics, no other company offers more FDA-cleared and CE-IVD-marked pathogen detection methods. BioFire Diagnostics provides the simplest, fastest, and most comprehensive multiplex PCR test: the BioFire system.